Professional Seasonal Analysis for Trading

Intellia Therapeutics, Inc. - Common Stock (NTLA)

Seasonality Analysis

Stocks 10 Years Analyzed

Intellia Therapeutics, Inc. - Common Stock Annual Seasonality Statistics

16.49%
Avg Annual Return
45.8%
Avg Monthly Win Rate
7/12
Positive Months
10
Years Analyzed

Intellia Therapeutics, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 1.87%
50%
Weak
February 4.78%
60%
Moderate
March -8.02%
20%
Very Weak
April -0.74%
50%
Weak
May 3.96%
40%
Weak
June BEST 20.07%
80%
Very Strong
July 1.76%
60%
Moderate
August 3.87%
50%
Weak
September -0.57%
30%
Very Weak
October WORST -10.02%
30%
Very Weak
November 5.76%
50%
Weak
December -6.22%
30%
Very Weak

Intellia Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
81.76
Historical Avg Position
36.19
Deviation
+45.57
Performance
Significantly Above Average

Intellia Therapeutics, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for NTLA with overlay patterns, custom date ranges, and more.

Create Free Account

Intellia Therapeutics, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Intellia Therapeutics, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for NTLA across multiple timeframes.

Create Free Account

About Intellia Therapeutics, Inc. - Common Stock (NTLA) Seasonality

Intellia Therapeutics, Inc. - Common Stock (NTLA) has been analyzed using 10 years of historical data to identify seasonal patterns. Classified under Stocks, Intellia Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Intellia Therapeutics, Inc. - Common Stock is historically June, with an average return of 20.07% and a win rate of 80%. Conversely, October tends to be the weakest month, averaging -10.02% return.

Looking at the full calendar year, Intellia Therapeutics, Inc. - Common Stock has an average annual return of 16.49% with an overall monthly win rate of 45.8%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Intellia Therapeutics, Inc. - Common Stock has a consistency score of 36.8 (Poor), based on 11 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Intellia Therapeutics, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Intellia Therapeutics, Inc. - Common Stock (NTLA)?

Historically, June has been the best month for Intellia Therapeutics, Inc. - Common Stock, with an average return of 20.07% and a win rate of 80%. However, past performance does not guarantee future results.

What is the worst month for Intellia Therapeutics, Inc. - Common Stock (NTLA)?

Based on historical data, October has been the weakest month for Intellia Therapeutics, Inc. - Common Stock, with an average return of -10.02%. This is a historical observation and does not guarantee future results.

How reliable is NTLA seasonality data?

The seasonality analysis for Intellia Therapeutics, Inc. - Common Stock is based on 10 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Intellia Therapeutics, Inc. - Common Stock seasonality in my trading?

Use Intellia Therapeutics, Inc. - Common Stock (NTLA) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.